NEW YORK (GenomeWeb News) – DCN Diagnostics today announced a deal with Asahi Kasei Fibers for the distribution of Asahi's cellulose nanobead product in North America.

Additionally, DCN, formerly called Diagnostic Consulting Network, will be the preferred provider of original equipment manufacturing services to users of Asahi's product, called NanoAct, worldwide, except in Japan, where Asahi is based.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.